Nifedipine and Antinuclear antibody positive - a phase IV clinical study of FDA data

Summary:

Antinuclear antibody positive is reported as a side effect among people who take Nifedipine (nifedipine), especially for people who are male, 60+ old, also take Lansoprazole, and have Bronchitis.

The phase IV clinical study analyzes which people have Antinuclear antibody positive when taking Nifedipine. It is created by eHealthMe based on reports of 52,610 people who have side effects when taking Nifedipine from the FDA, and is updated regularly.

What is Nifedipine?

Nifedipine has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 53,459 Nifedipine users. Check the latest studies of Nifedipine.

What is Antinuclear antibody positive?

Antinuclear antibody positive is found to be associated with 468 drugs and 673 conditions by eHealthMe. Check the latest studies of Antinuclear antibody positive.

On Aug, 09, 2026

52,610 people reported to have side effects when taking Nifedipine.
Among them, 29 people (0.06%) have Antinuclear antibody positive.

Could Nifedipine cause Antinuclear antibody positive?

Among these 29 people:

What is the gender of people who have Antinuclear antibody positive when taking Nifedipine? *

female: 18.52 %
male: 81.48 %

What is the age of people who have Antinuclear antibody positive when taking Nifedipine? *

What are other drugs people take besides Nifedipine? *

What are other side effects people have besides Antinuclear antibody positive? *

Weakness: 19 people, 65.52%
Dyspnea (difficult or laboured breathing): 18 people, 62.07%
Pain: 14 people, 48.28%
Alanine Aminotransferase Increased: 13 people, 44.83%
Ascites (accumulation of fluid in the abdominal cavity): 13 people, 44.83%
Aspartate Aminotransferase Increased: 13 people, 44.83%
Nausea (feeling of having an urge to vomit): 13 people, 44.83%
Abdominal Pain: 12 people, 41.38%
Bilirubin Conjugated Increased: 12 people, 41.38%
Faeces Pale: 12 people, 41.38%

What are the existing conditions these people have? *

Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 8 people, 27.59%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 7 people, 24.14%
Systemic Sclerosis (an autoimmune or connective tissue disease. it is characterized by thickening of the skin): 1 person, 3.45%
Pain: 1 person, 3.45%
Neuropathy Peripheral (surface nerve damage): 1 person, 3.45%
Ill-Defined Disorder: 1 person, 3.45%
Headache (pain in head): 1 person, 3.45%
Diabetes: 1 person, 3.45%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 3.45%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 3.45%

* Approximation only. Some reports may have incomplete information.

Do you take Nifedipine and have Antinuclear antibody positive?

- Check whether Antinuclear antibody positive is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nifedipine:

Nifedipine (53,459 reports)

Browse all side effects of Nifedipine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Antinuclear antibody positive:

Antinuclear antibody positive (468 drugs)

Browse all the conditions that are associated with Antinuclear antibody positive:

Antinuclear antibody positive (673 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nifedipine (the active ingredients of Nifedipine) and Nifedipine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.